1. Home
  2. QLGN vs WHLR Comparison

QLGN vs WHLR Comparison

Compare QLGN & WHLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • WHLR
  • Stock Information
  • Founded
  • QLGN 1996
  • WHLR 2011
  • Country
  • QLGN United States
  • WHLR United States
  • Employees
  • QLGN N/A
  • WHLR N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • WHLR Real Estate Investment Trusts
  • Sector
  • QLGN Health Care
  • WHLR Real Estate
  • Exchange
  • QLGN Nasdaq
  • WHLR Nasdaq
  • Market Cap
  • QLGN 2.4M
  • WHLR 2.8M
  • IPO Year
  • QLGN N/A
  • WHLR 2012
  • Fundamental
  • Price
  • QLGN $3.32
  • WHLR $3.29
  • Analyst Decision
  • QLGN
  • WHLR
  • Analyst Count
  • QLGN 0
  • WHLR 0
  • Target Price
  • QLGN N/A
  • WHLR N/A
  • AVG Volume (30 Days)
  • QLGN 111.5K
  • WHLR 373.7K
  • Earning Date
  • QLGN 04-15-2025
  • WHLR 05-05-2025
  • Dividend Yield
  • QLGN N/A
  • WHLR N/A
  • EPS Growth
  • QLGN N/A
  • WHLR N/A
  • EPS
  • QLGN N/A
  • WHLR N/A
  • Revenue
  • QLGN N/A
  • WHLR $104,307,000.00
  • Revenue This Year
  • QLGN N/A
  • WHLR N/A
  • Revenue Next Year
  • QLGN N/A
  • WHLR N/A
  • P/E Ratio
  • QLGN N/A
  • WHLR N/A
  • Revenue Growth
  • QLGN N/A
  • WHLR 2.26
  • 52 Week Low
  • QLGN $2.96
  • WHLR $2.92
  • 52 Week High
  • QLGN $29.45
  • WHLR $15,552.00
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 44.88
  • WHLR 20.79
  • Support Level
  • QLGN $3.06
  • WHLR $5.20
  • Resistance Level
  • QLGN $3.78
  • WHLR $4.50
  • Average True Range (ATR)
  • QLGN 0.28
  • WHLR 0.74
  • MACD
  • QLGN 0.03
  • WHLR 0.99
  • Stochastic Oscillator
  • QLGN 19.80
  • WHLR 11.65

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.

About WHLR Wheeler Real Estate Investment Trust Inc.

Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.

Share on Social Networks: